605507 Stock Overview
Engages in the research, development, production, and sale of products in the pharmaceutical and veterinary industries.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Guobang Pharma Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥18.02 |
| 52 Week High | CN¥22.93 |
| 52 Week Low | CN¥13.01 |
| Beta | 0.30 |
| 1 Month Change | 18.55% |
| 3 Month Change | 14.56% |
| 1 Year Change | -20.65% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -26.90% |
Recent News & Updates
Recent updates
Shareholder Returns
| 605507 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 1.0% | -0.2% | -0.8% |
| 1Y | -20.7% | -8.0% | -10.4% |
Return vs Industry: 605507 underperformed the CN Pharmaceuticals industry which returned -8% over the past year.
Return vs Market: 605507 underperformed the CN Market which returned -10.4% over the past year.
Price Volatility
| 605507 volatility | |
|---|---|
| 605507 Average Weekly Movement | 4.4% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 7.3% |
| 10% most volatile stocks in CN Market | 10.9% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 605507's share price has been volatile over the past 3 months.
Volatility Over Time: 605507's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 4,231 | n/a | www.gbgcn.com |
Guobang Pharma Ltd. engages in the research, development, production, and sale of products in the pharmaceutical and veterinary industries. Its products include quinolones, marcolides, cephalosporins, characteristic APIs, preparations and accessories, key pharmaceutical intermediates, mobile protection APIs, kinetophoretic preparations, and feed additives. The company sells its products approximately in 112 countries and regions worldwide.
Guobang Pharma Ltd. Fundamentals Summary
| 605507 fundamental statistics | |
|---|---|
| Market cap | CN¥10.01b |
| Earnings (TTM) | CN¥616.57m |
| Revenue (TTM) | CN¥5.28b |
16.2x
P/E Ratio1.9x
P/S RatioIs 605507 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 605507 income statement (TTM) | |
|---|---|
| Revenue | CN¥5.28b |
| Cost of Revenue | CN¥4.08b |
| Gross Profit | CN¥1.20b |
| Other Expenses | CN¥584.26m |
| Earnings | CN¥616.57m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.11 |
| Gross Margin | 22.75% |
| Net Profit Margin | 11.68% |
| Debt/Equity Ratio | 13.7% |
How did 605507 perform over the long term?
See historical performance and comparison